Company intelligence / Profile preview

OBISAN

Istanbul, Turkey

Ownership: Private
Development stage: Other

Overview

Obisan is a pharmaceutical company based in Turkey that specializes in the manufacturing and distribution of various medicinal products. The company is notably associated with the production of ondansetron-based treatments, which are used to manage nausea and vomiting, particularly those induced by chemotherapy or surgery. Obisan operates within the Turkish healthcare market, providing essential medications across several therapeutic categories. Its business model focuses on the commercialization of established pharmaceutical formulations to meet local and regional healthcare needs.

Therapeutic areas: Gastroenterology
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on OBISAN.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on OBISAN.

Explore the full profile